GENOME-WIDE EXPRESSION ANALYSIS
REVEALS DYSREGULATION OF MYELINATION-RELATED GENES IN CHRONIC SCHIZOPHRENIA
Kenneth L. Davis, Joseph Buxbaum,
Monte Buchsbaum, Philip D. Harvey, Patrick R. Hof, Joseph I. Friedman, Daniel G.
Stewart, Yaron Hakak, Allen A. Fienberg, Vahram Haroutunian
The Mount Sinai School of Medicine,
Department of Psychiatry, One Gustave L. Levy Place, New York, NY 10029
Neuropathological and brain imaging
studies suggest that schizophrenia may result from neurodevelopmental
defects. Cytoarchitectural studies indicate cellular abnormalities
suggestive of a disruption in neuronal connectivity in schizophrenia,
particularly n the dorsolateral prefrontal cortex. Yet, the molecular
substrates associated with schizophrenia, DNA microarray analysis was used to
assay gene expression levels in post-mortem dorsolateral prefrontal cortex of
schizophrenia and control patients. The most notable change was the
relative underexpression of myelination-related genes suggesting a disruption in
oligodendrocyte function in schizophrenia.
Myelination and those factors that
affect myelination, such as the function of oligodendroglia, are critical
processes that could profoundly affect neuronal connectivity, especially given
the diffuse distribution of oligodendrocytes and the widespread distribution of
brain regions that have been implicated in schizophrenia. Multiple lines
of evidence now converge to implicate oligodendroglia and myelin in
schizophrenia. Imaging and neurocytochemical evidence, similarities with
demyelinating disease, age-related changes in white matter, evidence for
myelin-related gene abnormalities, and consideration of the factors that impact
oligodendroglial function are examined as support for the hypothesis that
oligodendroglia dysfunction with subsequent abnormalities in myelin maintenance
and repair contribute to the schizophrenic syndrome in a subset of schizophrenic
patients.